Roy Fleishmann, MD (Chair)
Clinical Professor of Medicine
University of Texas Southwestern Medical Center
Co-Medical Director
Metroplex Clinical Research Center (MCRC)
Dallas, Texas Roy Fleishmann, MD, is a consultant for Abbott Laboratories, Amgen, Inc, Centocor, Inc, and UCB. He has received grant/research support from Abbott, Amgen, Wyeth, and Centocor.
Philip J. Mease, MD
Head, Seattle Rheumatology Associates
Clinical Professor
University of Washington School of Medicine
Seattle, Washington Philip J. Mease, MD is a consultant for Abbott Laboratories, Amgen, Inc, Biogen Idec, Bristol-Myers Squibb Company, Centocor, Inc, F. Hoffman-LaRoche Ltd, Genentech, Inc, UCB, and Wyeth Pharmaceuticals. He has received grant/research support from and has served on the speakers' bureaus for Abbott, Amgen, Biogen Idec, Bristol-Myers Squibb, Centocor, Genentech, and Wyeth.
Ronald F. van Vollenhoven, MD, PhD
Associate Professor of Rheumatology
Rheumatology Clinic
Karolinska University Hospital
Stockholm, Sweden Ronald F van Vollenhoven, MD, has nothing to disclose.
